BIO/Food Value Chain letter to Senate and House Appropriations Committee leadership in support of legislative language ensuring consistency under the National Bioengineered Food Disclosure Law

September 21, 2018

The Honorable Richard Shelby                                        The Honorable Patrick Leahy
Chairman                                                                          Vice Chairman
Committee on Appropriations                                          Committee on Appropriations
U.S. Senate                                                                       U.S. Senate
Washington, D.C. 20510                                                  Washington, D.C. 20510

The Honorable Rodney Frelinghuysen                            The Honorable Nita Lowey
Chairman                                                                          Ranking Member
Committee on Appropriations                                          Committee on Appropriations
U.S. House of Representatives                                        U.S. House of Representatives
Washington, D.C. 20515                                                 Washington, D.C. 20515

Dear Chairman Shelby, Chairman Frelinghuysen, Vice Chairman Leahy, and Ranking Member Lowey:

As representatives of the U.S. food value chain, we write to express our support for Section 766 of H.R. 5961, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY 2019, pertaining to product disclosure consistency under the National Bioengineered Food Disclosure Law (the “Disclosure Act”, or “the Act”). This provision will ensure that all bioengineered foods are properly disclosed to consumers consistent with the Disclosure Act, helping to prevent consumer confusion and increasing the Act’s value to consumers. Similarly, we oppose a conflicting provision in the Senate passed version of this legislation that would increase consumer confusion and undermine the intent of the Act...